• Home  
  • Artificial intelligence for antibiotic discovery and design
Artificial intelligence for antibiotic discovery and design
- Technology

Artificial intelligence for antibiotic discovery and design

Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022). Article  Google Scholar  Levy, S. B. The Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle https://doi.org/10.1007/978-1-4899-6042-9 (Springer, 1992). Silver, L. L. Challenges of antibacterial discovery. Clin. Microbiol. Rev. 24, 71–109 https://doi.org/10.1128/cmr.00030-10 (2011). Article  CAS  PubMed  PubMed

  • Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).

    Article 

    Google Scholar
     

  • Levy, S. B. The Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle https://doi.org/10.1007/978-1-4899-6042-9 (Springer, 1992).

  • Silver, L. L. Challenges of antibacterial discovery. Clin. Microbiol. Rev. 24, 71–109 https://doi.org/10.1128/cmr.00030-10 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Naghavi, M. et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet 404, 1199–1226 (2024).

    Article 
    CAS 

    Google Scholar
     

  • McDonnell, A. et al. Forecasting the Fallout From AMR: Economic Impacts of Antimicrobial Resistance in Humans. A Report From the EcoAMR Series https://doi.org/10.20506/ecoAMR.3539 (WOAH & World Bank, 2024).

  • Walsh, C. Where will new antibiotics come from? Nat. Rev. Microbiol. 1, 65–70 (2003).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Stover, C. K. et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405, 962–966 (2000).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Eyal, Z. et al. A novel pleuromutilin antibacterial compound, its binding mode and selectivity mechanism. Sci. Rep. 6, 39004 (2016).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Miller, A. A. et al. Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors. Antimicrob. Agents Chemother. 52, 2806–2812 (2008).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bax, B. D. et al. Type IIA topoisomerase inhibition by a new class of antibacterial agents. Nature 466, 935–940 (2010).

    Article 
    PubMed 

    Google Scholar
     

  • Yao, L. et al. Stepwise evolution and clonal enrichment of gepotidacin resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 70, e01706-25 (2026).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mukherjee, A. et al. Genetic background modulates zoliflodacin and gepotidacin cross-resistance and fitness in Neisseria gonorrhoeae. J. Infect. Dis. 234, e131–e140 (2026).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wan, F., Wong, F., Collins, J. J. & de la Fuente-Nunez, C. Machine learning for antimicrobial peptide identification and design. Nat. Rev. Bioeng. 2, 392–407 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Martins, H. G. W., Gorski, D., Mussa, B., Lazo, R. E. L. & Pontarolo, R. Artificial intelligence in drug discovery for fungal diseases: a scoping review. Artif. Intell. Med. 179, 103461 (2026).

    Article 
    PubMed 

    Google Scholar
     

  • Fu, C. et al. Leveraging machine learning essentiality predictions and chemogenomic interactions to identify antifungal targets. Nat. Commun. 12, 6497 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wensing, L. F. et al. Pooled CRISPRi screening reveals fungal-specific drug target candidates. Nat. Microbiol. 11, 2157–2169 (2026).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Behsaz, B. et al. Large-scale discovery platform enables identification of peptides targeting drug-resistant candidiasis. Cell Rep. Methods 6, 101510 https://doi.org/10.1016/j.crmeth.2026.101510 (2026).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pitt, W. R. et al. Real-world applications and experiences of AI/ML deployment for drug discovery. J. Med. Chem. 68, 851–859 (2025).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bender, A. et al. Artificial intelligence in drug discovery—what it is, where we stand and the path forward. Nat. Rev. Drug Discov. 25, 855–876 https://doi.org/10.1038/s41573-026-01496-2 (2026).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hutchings, M. I., Truman, A. W. & Wilkinson, B. Antibiotics: past, present and future. Curr. Opin. Microbiol. 51, 72–80 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Moloney, M. G. Natural products as a source for novel antibiotics. Trends Pharmacol. Sci. 37, 689–701 (2016).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Atanasov, A. G., Zotchev, S. B., Dirsch, V. M. & Supuran, C. T. Natural products in drug discovery: advances and opportunities. Nat. Rev. Drug Discov. 20, 200–216 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Martínez, J. L. Antibiotics and antibiotic resistance genes in natural environments. Science 321, 365–367 (2008).

    Article 
    PubMed 

    Google Scholar
     

  • Genilloud, O. Natural products discovery and potential for new antibiotics. Curr. Opin. Microbiol. 51, 81–87 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Okada, B. K. & Seyedsayamdost, M. R. Antibiotic dialogues: induction of silent biosynthetic gene clusters by exogenous small molecules. FEMS Microbiol. Rev. 41, 19–33 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Handelsman, J., Rondon, M. R., Brady, S. F., Clardy, J. & Goodman, R. M. Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chem. Biol. 5, R245–R249 (1998).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hover, B. M. et al. Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens. Nat. Microbiol. 3, 415–422 (2018).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang, Z., Koirala, B., Hernandez, Y., Zimmerman, M. & Brady, S. F. Bioinformatic prospecting and synthesis of a bifunctional lipopeptide antibiotic that evades resistance. Science 376, 991–996 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang, Z. et al. A naturally inspired antibiotic to target multidrug-resistant pathogens. Nature 601, 606–611 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hannigan, G. D. et al. A deep learning genome-mining strategy for biosynthetic gene cluster prediction. Nucleic Acids Res. 47, e110 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Glassey, E., Zhang, Z., King, A. M., Niquille, D. L. & Voigt, C. A. De novo design of ribosomally synthesized and post-translationally modified peptides. Nat. Chem. 17, 233–245 (2025).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Modaresi, S. M. et al. Antibiotics that kill Gram-negative bacteria by restructuring the outer membrane protein BamA. Preprint at bioRxiv https://doi.org/10.1101/2024.12.16.628070 (2024).

  • Morrison, K. C. & Hergenrother, P. J. Natural products as starting points for the synthesis of complex and diverse compounds. Nat. Prod. Rep. 31, 6–14 (2013).

    Article 

    Google Scholar
     

  • Nicolaou, K. C. & Rigol, S. A brief history of antibiotics and select advances in their synthesis. J. Antibiot. 71, 153–184 (2018).

    Article 
    CAS 

    Google Scholar
     

  • Liu, R., Li, X. & Lam, K. S. Combinatorial chemistry in drug discovery. Curr. Opin. Chem. Biol. 38, 117–126 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Macarron, R. et al. Impact of high-throughput screening in biomedical research. Nat. Rev. Drug Discov. 10, 188–195 (2011).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Grygorenko, O. O. et al. Generating multibillion chemical space of readily accessible screening compounds. iScience 23, 101681 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Korn, M., Ehrt, C., Ruggiu, F., Gastreich, M. & Rarey, M. Navigating large chemical spaces in early-phase drug discovery. Curr. Opin. Struct. Biol. 80, 102578 (2023).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sadybekov, A. V. & Katritch, V. Computational approaches streamlining drug discovery. Nature 616, 673–685 (2023).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Heid, E. et al. Chemprop: a machine learning package for chemical property prediction. J. Chem. Inf. Model. 64, 9–17 (2024).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Burns, J. W. et al. Deep learning foundation models for low-data regimes from classical molecular descriptors. J. Chem. Inf. Model. 66, 10692–10701 (2026).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Krenn, M., Häse, F., Nigam, A., Friederich, P. & Aspuru-Guzik, A. Self-referencing embedded strings (SELFIES): a 100% robust molecular string representation. Mach. Learn. Sci. Technol. 1, 045024 (2020).

    Article 

    Google Scholar
     

  • Vaswani, A. et al. Attention is all you need. In Advances in Neural Information Processing Systems 30 (eds Guyon, I. et al.) 6000–6010 (Curran Associates, 2017).

  • Chithrananda, S., Grand, G. & Ramsundar, B. ChemBERTa: large-scale self-supervised pretraining for molecular property prediction. Preprint at https://doi.org/10.48550/arXiv.2010.09885 (2020).

  • Ross, J. et al. Large-scale chemical language representations capture molecular structure and properties. Nat. Mach. Intell. 4, 1256–1264 (2022).

    Article 

    Google Scholar
     

  • Zhou, G., Janarthanan, S., Lu, Y. & Hu, P. CL-MFAP: a contrastive learning-based multimodal foundation model for molecular property prediction and antibiotic screening. In Proc. 13th International Conference on Learning Representations (eds Yue, Y. et al.) 62386–62406 (ICLR, 2025).

  • Nguyen, E., Hong, Y., Toshniwal, H., Liu, Y. & Luttens, A. GLACIER: a multimodal student–teacher foundation model for molecular property prediction. In Proc. 32nd ACM SIGKDD Conf. Knowledge Discovery and Data Mining V.2 (eds Kim, W. et al.) 11705–11716 https://doi.org/10.1145/3770855.3819032 (Association for Computing Machinery, 2026).

  • Stokes, J. M. et al. A deep learning approach to antibiotic discovery. Cell 180, 688–702.e13 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liu, G. et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat. Chem. Biol. 19, 1342–1350 (2023).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Anahtar, M. N. et al. Deep learning-enabled discovery of antibiotics effective against Neisseria gonorrhoeae. Sci. Transl. Med. 18, eads4699 https://doi.org/10.1126/scitranslmed.ads4699 (2026).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zheng, E. J. et al. Discovery of antibiotics that selectively kill metabolically dormant bacteria. Cell Chem. Biol. 31, 712–728.e9 (2024).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Scalia, G. et al. Deep-learning-based virtual screening of antibacterial compounds. Nat. Biotechnol. 44, 1154–1167 https://doi.org/10.1038/s41587-025-02814-6 (2025).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wong, F. et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature 626, 177–185 (2024).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Avis, T., Wilson, F. X., Khan, N., Mason, C. S. & Powell, D. J. Targeted microbiome-sparing antibiotics. Drug Discov. Today 26, 2198–2203 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lavecchia, A. Deep learning in drug discovery: opportunities, challenges and future prospects. Drug Discov. Today 24, 2017–2032 (2019).

    Article 
    PubMed 

    Google Scholar
     

  • Buterez, D., Janet, J. P., Kiddle, S. J., Oglic, D. & Lió, P. Transfer learning with graph neural networks for improved molecular property prediction in the multi-fidelity setting. Nat. Commun. 15, 1517 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Janarthanan, S., Zhou, G., Li, Y. Y., Jing, Z. & Hu, P. Leveraging transfer learning and multimodal foundation models for antibiotic discovery against data-scarce Escherichia coli strains. In ICLR 2025 Workshops: LMRL (ICLR, 2025).

  • Simm, J. et al. Splitting chemical structure data sets for federated privacy-preserving machine learning. J. Cheminform. 13, 96 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jiménez-Luna, J., Grisoni, F. & Schneider, G. Drug discovery with explainable artificial intelligence. Nat. Mach. Intell. 2, 573–584 (2020).

    Article 

    Google Scholar
     

  • Huynh, D. L. et al. AI agents in drug discovery: applications and case studies. Drug Discov. Today 31, 104650 (2026).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wei, Z. et al. Fleming: an AI agent for antibiotic discovery in Mycobacterium tuberculosis. Preprint at bioRxiv https://doi.org/10.1101/2025.04.01.646719 (2025).

  • Moffat, J. G., Vincent, F., Lee, J. A., Eder, J. & Prunotto, M. Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nat. Rev. Drug Discov. 16, 531–543 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Mateus, A. et al. Thermal proteome profiling in bacteria: probing protein state in vivo. Mol. Syst. Biol. 14, e8242 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Choe, D. et al. Rapid identification of key antibiotic resistance genes in E. coli using high-resolution genome-scale CRISPRi screening. iScience 28, 112435 (2025).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Briffotaux, J., Liu, S. & Gicquel, B. Genome-wide transcriptional responses of Mycobacterium to antibiotics. Front. Microbiol. 10, 249 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zampieri, M. et al. High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds. Sci. Transl. Med. 10, eaal3973 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nonejuie, P., Burkart, M., Pogliano, K. & Pogliano, J. Bacterial cytological profiling rapidly identifies the cellular pathways targeted by antibacterial molecules. Proc. Natl Acad. Sci. USA 110, 16169–16174 (2013).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • McQuin, C. et al. CellProfiler 3.0: next-generation image processing for biology. PLoS Biol. 16, e2005970 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gardner, T. S., di Bernardo, D., Lorenz, D. & Collins, J. J. Inferring genetic networks and identifying compound mode of action via expression profiling. Science 301, 102–105 (2003).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Yang, J. H. et al. A white-box machine learning approach for revealing antibiotic mechanisms of action. Cell 177, 1649–1661.e9 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Smith, T. C. et al. Morphological profiling of tubercle bacilli identifies drug pathways of action. Proc. Natl Acad. Sci. USA 117, 18744–18753 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Quach, D. et al. Deep learning-driven bacterial cytological profiling to determine antimicrobial mechanisms in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 122, e2419813122 (2025).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bond, A. N. et al. Reference-based chemical-genetic interaction profiling to elucidate small molecule mechanism of action in Mycobacterium tuberculosis. Nat. Commun. 16, 9673 (2025).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Swinney, D. C. Phenotypic vs. target-based drug discovery for first-in-class medicines. Clin. Pharmacol. Ther. 93, 299–301 https://doi.org/10.1038/clpt.2012.236 (2013).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Gironda-Martínez, A., Donckele, E. J., Samain, F. & Neri, D. DNA-encoded chemical libraries: a comprehensive review with successful stories and future challenges. ACS Pharmacol. Transl. Sci. 4, 1265–1279 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • McCloskey, K. et al. Machine learning on DNA-encoded libraries: a new paradigm for hit finding. J. Med. Chem. 63, 8857–8866 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Anderson, A. C. The process of structure-based drug design. Chem. Biol. 10, 787–797 (2003).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Larsen, A. S., Rekis, T. & Madsen, A. Ø PhAI: a deep-learning approach to solve the crystallographic phase problem. Science 385, 522–528 (2024).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Qu, X. et al. Accelerated nuclear magnetic resonance spectroscopy with deep learning. Angew. Chem. Int. Ed. 59, 10297–10300 (2020).

    Article 
    CAS 

    Google Scholar
     

  • Giri, N., Roy, R. S. & Cheng, J. Deep learning for reconstructing protein structures from cryo-EM density maps: recent advances and future directions. Curr. Opin. Struct. Biol. 79, 102536 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Carlsson, J. & Luttens, A. Structure-based virtual screening of vast chemical space as a starting point for drug discovery. Curr. Opin. Struct. Biol. 87, 102829 (2024).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bender, B. J. et al. A practical guide to large-scale docking. Nat. Protoc. 16, 4799–4832 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yang, Y. et al. Efficient exploration of chemical space with docking and deep learning. J. Chem. Theory Comput. 17, 7106–7119 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Gentile, F. et al. Deep docking: a deep learning platform for augmentation of structure based drug discovery. ACS Cent. Sci. 6, 939–949 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Luttens, A. et al. Rapid traversal of vast chemical space using machine learning-guided docking screens. Nat. Comput. Sci. 5, 301–312 (2025).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Krishna, R. et al. Generalized biomolecular modeling and design with RoseTTAFold All-Atom. Science 384, eadl2528 (2024).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Passaro, S. et al. Boltz-2: towards accurate and efficient binding affinity prediction. Preprint at bioRxiv https://doi.org/10.1101/2025.06.14.659707 (2025).

  • Wong, F. et al. Benchmarking AlphaFold-enabled molecular docking predictions for antibiotic discovery. Mol. Syst. Biol. 18, e11081 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lyu, J. et al. AlphaFold2 structures guide prospective ligand discovery. Science 384, eadn6354 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Díaz-Holguín, A. et al. AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1. Sci. Adv. 10, eadn1524 (2024).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Peng, X. et al. Unified modeling of 3D molecular generation via atomic interactions with PocketXMol. Cell 189, 1904–1922 (2026).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Aggarwal, R., Gupta, A., Chelur, V., Jawahar, C. V. & Priyakumar, U. D. DeepPocket: ligand binding site detection and segmentation using 3D convolutional neural networks. J. Chem. Inf. Model. 62, 5069–5079 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • He, W. et al. A broad-spectrum antibiotic targets multiple-drug-resistant bacteria with dual binding targets and no detectable resistance. Nat. Commun. 16, 7048 (2025).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Martin, J. K. et al. A dual-mechanism antibiotic kills Gram-negative bacteria and avoids drug resistance. Cell 181, 1518–1532.e14 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O. & Piddock, L. J. V. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 13, 42–51 (2015).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Blair, J. M., Richmond, G. E. & Piddock, L. J. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol. 9, 1165–1177 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Motika, S. E. et al. Gram-negative antibiotic active through inhibition of an essential riboswitch. J. Am. Chem. Soc. 142, 10856–10862 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shen, T. et al. Accurate RNA 3D structure prediction using a language model-based deep learning approach. Nat. Methods 21, 2287–2298 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wong, F. et al. Deep generative design of RNA aptamers using structural predictions. Nat. Comput. Sci. 4, 829–839 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Carvajal-Patiño, J. G. et al. RNAmigos2: accelerated structure-based RNA virtual screening with deep graph learning. Nat. Commun. 16, 2799 (2025).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bohacek, R. S., McMartin, C. & Guida, W. C. The art and practice of structure-based drug design: a molecular modeling perspective. Med. Res. Rev. 16, 3–50 (1996).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Tingle, B. I. et al. ZINC-22—a free multi-billion-scale database of tangible compounds for ligand discovery. J. Chem. Inf. Model. https://doi.org/10.1021/acs.jcim.2c01253 (2023).

  • Gangwal, A. & Lavecchia, A. Unleashing the power of generative AI in drug discovery. Drug Discov. Today 29, 103992 (2024).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3–25 (1997).

    Article 
    CAS 

    Google Scholar
     

  • Swanson, K. et al. SyntheMol-RL: a flexible reinforcement learning framework for designing easily synthesizable antibiotics. Mol. Syst. Biol. 22, 833–867 (2026).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Swanson, K. et al. Generative AI for designing and validating easily synthesizable and structurally novel antibiotics. Nat. Mach. Intell. 6, 338–353 (2024).

    Article 

    Google Scholar
     

  • Seo, S. et al. Generative flows on synthetic pathway for drug design. In Proc. 13th International Conference on Learning Representations (eds Yue, Y. et al.) 14029–14060 (ICLR, 2025).

  • Klarich, K., Goldman, B., Kramer, T., Riley, P. & Walters, W. P. Thompson sampling—an efficient method for searching ultralarge synthesis on demand databases. J. Chem. Inf. Model. 64, 1158–1171 https://doi.org/10.1021/acs.jcim.3c01790 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gao, W., Luo, S. & Coley, C. W. Generative AI for navigating synthesizable chemical space. Proc. Natl Acad. Sci. USA 122, e2415665122 (2025).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang, Y. et al. A generative artificial intelligence approach for the discovery of antimicrobial peptides against multidrug-resistant bacteria. Nat. Microbiol. 10, 2997–3012 (2025).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Szymczak, P. et al. Discovering highly potent antimicrobial peptides with deep generative model HydrAMP. Nat. Commun. 14, 1453 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Watson, J. L. et al. De novo design of protein structure and function with RFdiffusion. Nature 620, 1089–1100 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Torres, M. D. T., Chen, L. T., Wan, F., Chatterjee, P. & de la Fuente-Nunez, C. Generative latent diffusion language modeling yields anti-infective synthetic peptides. Cell Biomater. 1, 100183 (2025).

    Article 

    Google Scholar
     

  • Torres, M. D. T. et al. A generative artificial intelligence approach for peptide antibiotic optimization. Nat. Mach. Intell. 8, 841–856 (2026).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Polishchuk, P. CReM: chemically reasonable mutations framework for structure generation. J. Cheminform. 12, 28 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jin, W., Barzilay, R. & Jaakkola, T. Junction tree variational autoencoder for molecular graph generation. In Proc. 35th International Conference on Machine Learning (eds Dy, J. & Krause, A.) 2323–2332 (PMLR, 2018).

  • Krishnan, A. et al. A generative deep learning approach to de novo antibiotic design. Cell 188, 5962–5979.e22 (2025).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gao, W. & Coley, C. W. The synthesizability of molecules proposed by generative models. J. Chem. Inf. Model. 60, 5714–5723 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ertl, P. & Schuffenhauer, A. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J. Cheminform. 1, 8 (2009).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Thakkar, A., Chadimová, V., Bjerrum, E. J., Engkvist, O. & Reymond, J.-L. Retrosynthetic accessibility score (RAscore)—rapid machine learned synthesizability classification from AI driven retrosynthetic planning. Chem. Sci. 12, 3339–3349 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tu, Z. et al. ASKCOS: open-source, data-driven synthesis planning. Acc. Chem. Res. 58, 1764–1775 (2025).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Fromer, J. C. & Coley, C. W. An algorithmic framework for synthetic cost-aware decision making in molecular design. Nat. Comput. Sci. 4, 440–450 (2024).

    Article 
    PubMed 

    Google Scholar
     

  • Dekleva, D. et al. Synthesizability via reward engineering: expanding generative molecular design into synthetic space. Chem. Sci. 17, 10015–10028 (2026).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sundin, I. et al. Human-in-the-loop assisted de novo molecular design. J. Cheminform. 14, 86 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lipinski, C. A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 44, 235–249 (2000).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Swanson, K. et al. ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries. Bioinformatics 40, btae416 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kola, I. & Landis, J. Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3, 711–716 (2004).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lipinski, C. A. Lead- and drug-like compounds: the rule-of-five revolution. Drug. Discov. Today Technol. 1, 337–341 (2004).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Fraser, J. S. et al. Mapping the avoid-ome: a systematic open-science approach to predictive ADMET. Nat. Commun. 17, 4644 (2026).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Huang, K. et al. Therapeutics Data Commons: machine learning datasets and tasks for drug discovery and development. In Proc. 35th Neural Information Processing Systems Track on Datasets and Benchmarks 1 121 (NeurIPS, 2021).

  • Fralish, Z., Chen, A., Skaluba, P. & Reker, D. DeepDelta: predicting ADMET improvements of molecular derivatives with deep learning. J. Cheminform. 15, 101 (2023).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Masi, M., Réfregiers, M., Pos, K. M. & Pagès, J.-M. Mechanisms of envelope permeability and antibiotic influx and efflux in Gram-negative bacteria. Nat. Microbiol. 2, 17001 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zgurskaya, H. I., López, C. A. & Gnanakaran, S. Permeability barrier of Gram-negative cell envelopes and approaches to bypass it. ACS Infect. Dis. 1, 512–522 https://doi.org/10.1021/acsinfecdis.5b00097 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Du, D. et al. Multidrug efflux pumps: structure, function and regulation. Nat. Rev. Microbiol. 16, 523–539 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Muñoz, K. A. & Hergenrother, P. J. Facilitating compound entry as a means to discover antibiotics for Gram-negative bacteria. Acc. Chem. Res. 54, 1322–1333 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Plé, C. et al. Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps. Nat. Commun. 13, 115 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gurvic, D. & Zachariae, U. Multidrug efflux in Gram-negative bacteria: structural modifications in active compounds leading to efflux pump avoidance. npj Antimicrob. Resist. 2, 6 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lepori, I. et al. Identification of chemical features for improved outer membrane permeation in mycobacteria using machine learning. Nat. Microbiol. 11, 2647–2665 https://doi.org/10.1038/s41564-026-02412-5 (2026).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rayner, B., Verderosa, A. D., Ferro, V. & Blaskovich, M. A. T. Siderophore conjugates to combat antibiotic-resistant bacteria. RSC Med. Chem. 14, 800–822 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pelgrift, R. Y. & Friedman, A. J. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv. Drug Deliv. Rev. 65, 1803–1815 (2013).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Paul-Satyaseela, M. Invention of enmetazobactam: an Indian triumph in antimicrobial drug discovery. ACS Infect. Dis. 11, 1–3 (2025).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Durand-Réville, T. F. et al. ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii. Nat. Microbiol. 2, 17104 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • Isoda, T. et al. Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084. J. Antibiot. 59, 241–247 (2006).

    Article 
    CAS 

    Google Scholar
     

  • Novak, R. & Shlaes, D. M. The pleuromutilin antibiotics: a new class for human use. Curr. Opin. Investig. Drugs 11, 182–191 (2010).

    CAS 
    PubMed 

    Google Scholar
     

  • Ito, A. et al. Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 60, 7396–7401 (2016).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xu, F., Sherry, B. D. & Blizzard, T. A. Discovery and chemical development of relebactam: a potent β-lactamase inhibitor in combination with Primaxin for the treatment of serious and antibiotic-resistant bacterial infections. In Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3 (eds Pesti, J. A. et al.) 253–284 (American Chemical Society, 2020).

  • Aggen, J. B. et al. Synthesis and spectrum of the neoglycoside ACHN-490. Antimicrob. Agents Chemother. 54, 4636–4642 https://doi.org/10.1128/aac.00572-10 (2010).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liu, F. & Myers, A. G. Development of a platform for the discovery and practical synthesis of new tetracycline antibiotics. Curr. Opin. Chem. Biol. 32, 48–57 (2016).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Moore, A. Y., Rosso, J. D., Johnson, J. L. & Grada, A. Sarecycline: a review of preclinical and clinical evidence. Clin. Cosmet. Investig. Dermatol. 13, 553–560 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Honeyman, L. et al. Structure–activity relationship of the aminomethylcyclines and the discovery of omadacycline. Antimicrob. Agents Chemother. 54, 7044–7053 https://doi.org/10.1128/aac.01536-15 (2015).

    Article 

    Google Scholar
     

  • Coleman, K. Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors. Curr. Opin. Microbiol. 14, 550–555 (2011).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Minamimura, M., Taniyama, Y., Inoue, R. & Mitsuhashi, S. In vitro antibacterial activity and β-lactamase stability of CP-70,429 a new penem antibiotic. Antimicrob. Agents Chemother. 37, 1547–1551 https://doi.org/10.1128/aac.37.7.1547 (1993).

    Article 
    CAS 

    Google Scholar
     

  • Yao, R. et al. Sudapyridine (WX-081), a novel compound against Mycobacterium tuberculosis. Microbiol. Spectr. 10, e02477-21 (2022).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hariguchi, N. et al. OPC-167832, a novel carbostyril derivative with potent antituberculosis activity as a DprE1 Inhibitor. Antimicrob. Agents Chemother. 64, e02020-19 https://doi.org/10.1128/aac.02020-19 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pethe, K. et al. Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nat. Med. 19, 1157–1160 (2013).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Suckling, C. J. The antibacterial drug MGB-BP3: from discovery to clinical trial. Chem. Biol. Interface 5, 166–174 (2015).

    CAS 

    Google Scholar
     

  • Li, X. et al. Discovery of a potent and specific M. tuberculosis leucyl-tRNA synthetase inhibitor: (S)-3-(aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656). J. Med. Chem. 60, 8011–8026 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Brown, P. et al. Design of next generation polymyxins with lower toxicity: the discovery of SPR206. ACS Infect. Dis. 5, 1645–1656 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Robertson, G. T. et al. In vitro evaluation of CBR-2092, a novel rifamycin–quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus. Antimicrob. Agents Chemother. 52, 2313–2323 https://doi.org/10.1128/aac.01649-07 (2008).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Willand, N. et al. Synthetic EthR inhibitors boost antituberculous activity of ethionamide. Nat. Med. 15, 537–544 (2009).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Han, Z. et al. Structure-based drug design and optimization of mannoside bacterial FimH antagonists. J. Med. Chem. 53, 4779–4792 (2010).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kaul, M. et al. TXA709, an FtsZ-targeting benzamide prodrug with improved pharmacokinetics and enhanced in vivo efficacy against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 59, 4845–4855 https://doi.org/10.1128/aac.00708-15 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Payne, D. J. et al. Discovery of a novel and potent class of FabI-directed antibacterial agents. Antimicrob. Agents Chemother. 46, 3118–3124 https://doi.org/10.1128/aac.46.10.3118-3124.2002 (2002).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Slingerland, C. J. et al. Synthesis and evaluation of polymyxins bearing reductively labile disulfide-linked lipids. J. Med. Chem. 65, 15878–15892 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zampaloni, C. et al. A novel antibiotic class targeting the lipopolysaccharide transporter. Nature 625, 566–571 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Source: www.nature.com

    About Us

    Toolq Media Is a Global News Platform Covering the Latest Developments and Breaking Stories from Around The World, Including World News, Business, Finance, Technology, Health, Politics, Science, Entertainment, Sports, and More.

    Toolq

    Toolq @2026. All Rights Reserved.